Early assessment of leukocyte alterations at diagnosis of septic shock

Shock

Volumn 34, Issue 4, 2010, Pages 358-363

  Venet, Fabienne ^a   Davin, Fanny ^b   Guignant, Caroline ^b   Larue, Audrey ^b   Cazalis, Marie Angélique ^b   Darbon, Romain ^b   Allombert, Caroline ^b   Mougin, Bruno ^b   Malcus, Christophe ^b   Poitevin Later, Françoise ^b   Lepape, Alain ^a,c   Monneret, Guillaume ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c University Hospitals of Lyon   (France)

Author keywords

FOXP3; GATA 3; lymphocyte; ROR ; Septic shock; T bet

Indexed keywords

MESSENGER RNA; PROTEIN GAMMA ROR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; COMORBIDITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE; LEUKOCYTOSIS; LYMPHOCYTOPENIA; MALE; NEUTROPHILIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; TH1 CELL; TH17 CELL; TH2 CELL;

AGED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; T-BOX DOMAIN PROTEINS;

EID: 77957690699     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181dc0977     Document Type: Article

References (34)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
3. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 365:63-78, 2005.
4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hos-pitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244-1250, 2007.
5. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14: 64-78, 2008.
6. Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, Trouillet JL, Capron F, Agut H, Gibert C, Chastre J: Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 175:935-942, 2007.
7. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, et al.: Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413-422, 2008.
8. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321, 2001.
9. Pugin J: Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 280:21-27; discussion 27-36, 160-164, 2007.
10. Nishijima MK, Takezawa J, Hosotsubo KK, Takahashi H, Shimada Y, Yoshiya I: Serial changes in cellular immunity of septic patients with multiple organ-system failure. Crit Care Med 14:87-91, 1986.
11. McCredie JA, Austin TW, Holliday RL, Sibbald WJ: Predictive value for survival of lymphocytes and polymorphonuclear leukocytes in patients with sepsis. Can J Surg 22:447-451, 1979.
12. H2 predominance. Biochem Biophys Res Commun 308:840-846, 2003.
13. Levy EM, Alharbi SA, Grindlinger G, Black PH: Changes in mitogen responsiveness lymphocyte subsets after traumatic injury: relation to development of sepsis. Clin Immunol Immunopathol 32:224-233, 1984.
14. Antonacci AC, Reaves LE, Calvano SE, Amand R, De Riesthal HF, Shires GT: Flow cytometric analysis of lymphocyte subpopulations after thermal injury in human beings. Surg Gynecol Obstet 159:1-8, 1984.
15. Cheadle WG, Mercer-Jones M, Heinzelmann M, Polk HC Jr: Sepsis and septic complications in the surgical patient: who is at risk? Shock 6(suppl 1):S6YS9, 1996.
16. Dahn MS, Whitcomb MP, Lange MP, Jacobs LA: Altered T-lymphocyte subsets in severe sepsis. Am Surg 54:450-455, 1988.
17. Oberholzer C, Oberholzer A, Bahjat FR, Minter RM, Tannahill CL, Abouhamze A, LaFace D, Hutchins B, Clare-Salzler MJ, Moldawer LL: Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci\USA 98: 11503-11508, 2001.
18. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE: Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci\USA 96:14541-14546, 1999.
19. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, et al.: Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496-501, 2000.
20. Manjuck J, Saha DC, Astiz M, Eales LJ, Rackow EC: Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 135:153-160, 2000.
21. Monserrat J, De Pablo R, Reyes E, Diaz D, Barcenilla H, Zapata MR, De la Hera A, Prieto A, Alvarez-Mon M: Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care 13:R26, 2009.
22. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483, 1992.
23. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963, 1993.
24. Pachot A, Monneret G, Brion A, Venet F, Bohe J, Bienvenu J, Mougin B, Lepape A: Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33:31-38; discussion 236-237, 2005.
25. j lymphocytes. Crit Care Med 32:2329-2331, 2004.
26. Shelley O, Murphy T, Paterson H, Mannick JA, Lederer JA: Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 20:123-129, 2003.
27. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE: Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 174:5110-5118, 2005.
28. + T lymphocytes in humans. J Immunol 166:6952-6963, 2001.
29. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA: Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174:3765-3772, 2005.
30. Venet F, Bohe J, Debard AL, Bienvenu J, Lepape A, Monneret G: Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 33:2836-2840, 2005.
31. + expression in sepsis. Clin Microbiol Infect 6:657-660, 2000.
32. PachotA, Monneret G, Voirin N, Leissner P, Venet F, Bohe J, Payen D, Bienvenu J, Mougin B, Lepape A: Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol 114:61-69, 2005.
33. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL, et al.: Adverse functions of IL-17A in experimental sepsis. FASEB J 22:2198-2205, 2008.
34. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G: Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (j)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35:678-686, 2009.